TIA supports the development of new therapeutics through the provision of hard infrastructure for translational research, by providing expertise through the Virtual Pharma Network and the Queensland Node of TIA.
Provision of Infrastructure
For a detailed description of the capabilities available in TIA’s National consortium please click here
. You can also read more about Biopharmaceuticals, Cell-based Therapies, Clinical Trials Infrastructure, Drug Screening, Integrated Preclinical Capability, Personalised Medicine and Pharmacometrics facilities, as well as the National Regulatory Repository, via the links on the main menu.
Provision of Expertise
The Virtual Pharma Network
and the TIA – Queensland Node
provide advice on all aspects of new therapeutic development.